Due: April 17, 2026
CPE CBRND is conducting essential market research for the Prophylaxis in Advanced Development (PAD) program, a new initiative expected to launch in Fiscal Year 2028. This program is dedicated to identifying and advancing high-impact innovative prophylactic candidates that can provide reliable, mission-enabling protection for our military personnel against both endemic and weaponized pathogens as outlined in the Medical Management of Biologic Casualties Handbook.
Responding to this opportunity requires membership in the Medical CBRN Defense Consortium (MCDC). This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.